A potent, bioavailable ACAT inhibitor may have beneficial effects in the treatment of atherosclerosis by (i) reducing the absorption of dietary cholesterol, (ii) reducing the secretion of very low density lipoproteins into plasma from the liver, and (iii) preventing the transformation of arterial macrophages into foam cells. We have found that a mevalonate derivative 2, which contains a 4,5-diphenyl-1H-imidazol-2-yl moiety, inhibits rat hepatic microsomal ACAT in vitro and produces a significant hypocholesterolemic effect in the cholesterol-fed rat. Structure-activity relationships for analogues of 2 demonstrate that the 4,5-diphenyl-1H-imidazole moiety is a pharmacophore for inhibition of rat microsomal ACAT.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm00101a016DOI Listing

Publication Analysis

Top Keywords

microsomal acat
8
acat
5
acyl-coacholesterol o-acyl
4
o-acyl transferase
4
transferase acat
4
acat inhibitors
4
inhibitors 2-alkylthio-45-diphenyl-1h-imidazoles
4
2-alkylthio-45-diphenyl-1h-imidazoles potent
4
potent inhibitors
4
inhibitors acat
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!